Compugen | CGEN - Ebitda


Compugen reported $-7.89M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Arca Biopharma USD -25.07M 5.23M Mar/2025
aTyr Pharma USD -26.58M 26.32M Sep/2025
Bio Path USD -3.21M 631K Mar/2025
Brainstorm Cell Therapeutics USD -3.04M 99K Mar/2025
Cara Therapeutics USD -2.39M 3.16M Mar/2025
Clal Biotechnology ILS -5.3M 2.09M Dec/2022
Compugen USD -7.89M 536K Sep/2025
Immunic USD -22.78M 753K Jun/2024
Infinity Pharmaceuticals USD -10.01M 1.39M Jun/2023
Minerva Neurosciences USD -4.36M 1.71M Sep/2024
RedHill Biopharma USD 2.69M 108.46M Jun/2023
TherapeuticsMD USD -1.64M 700K Sep/2023